“…The risk of breast cancer recurrence is determined primarily by histopathological evaluations of the tumor, the results of which are used to guide the therapeutic management of patients. However, genetic, epigenetic, and transcriptomic alterations have been identified in cancer-adjacent tissues of many epithelial cancers, including head and neck [7,12], colorectal [13,[42][43][44], skin [45,46], bladder [13,[47][48][49], lung [14,50], prostate [8,13,51,52], ovarian [53,54], and breast [10,[13][14][15][18][19][20][55][56][57][58][59][60][61][62][63][64][65][66][67][68]. Moreover, persistent exposure to environmental risk factors (e.g.…”